AYUMI Pharmaceutical Overview

Life ScienceCompany

Is AYUMI Pharmaceutical PE-backed?

Yes. AYUMI Pharmaceutical is owned by private equity investor The Blackstone Group.

Was AYUMI Pharmaceutical formerly PE-backed?

Yes. AYUMI Pharmaceutical was formerly owned by 1 private investor.

Where is AYUMI Pharmaceutical headquartered?

AYUMI Pharmaceutical is headquartered in Tokyo, Japan.

What sector is AYUMI Pharmaceutical in?

AYUMI Pharmaceutical is a life science company.

When was AYUMI Pharmaceutical founded?

AYUMI Pharmaceutical was founded in 2015.

AYUMI Pharmaceutical

AYUMI Pharmaceutical Corp.

Kabukiza Tower 19F, 4-12-15 Ginza,
Tokyo, 104-0061
Japan,
+81-3-6264-3540
www.ayumi-pharma.com

AYUMI Pharmaceutical is a manufacturer and sale of medicines used in the treatment of rheumatism and other pharmaceuticals. AYUMI Pharmaceutical was founded in 2015 and is based in Tokyo, Japan.



Try Mergr Free — See This and 220,573+
Other Company and Investor Profiles Today

Try free. Full access. Cancel anytime.

  • check  Unlimited Searches
  • check  Unlimited Profile Views
  • check  Build and Export Lists of
    • PE Backed Companies
    • Direct Investors & Acquirers
    • Advisors
    • Deals
    • & More

What's Mergr?

Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.

We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.

With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.

Mergr, the Easiest-to-Use PE and M&A DB


Key Benefits

  • Stay informed on events in your industry
  • M&A research that takes seconds (not all afternoon)
  • Better understand your customers and prospects
  • Discover active buyers (or sellers)
Search
  • 4.8K Private Equity Firms
  • 214K M&A Transactions
  • 216K Companies Involved in M&A
    (Buyer, Seller, or Target)
  • 3.8K M&A Advisors
    (Investment Banks and Law Firms)
  • 83K M&A Contacts
    (PE and M&A Advisors)

What next?

Try Free

Full access to Mergr's investor, acquirer, and transaction data starts here.

Related Lists for AYUMI Pharmaceutical

Life Science Companies , Japan Companies